|
Nu Skin Enterprises Inc (NYSE: NUS) |
|
Nu Skin Enterprises Inc
NUS's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Nu Skin Enterprises Inc 's sales fell
by -12.41 % in II. Quarter 2024 from the same quarter a year ago.
Ranking at No. 2331
Pharmacy Services & Retail Drugstore industry recorded
growth of revenues by 5.58 %
Nu Skin Enterprises Inc faced net loss in contrast to the net income a year ago in II. Quarter 2024
• More on NUS's Growth
|
|
Nu Skin Enterprises Inc realized a net loss in trailing twelve months.
Nu Skin Enterprises Inc realized cash reduction of $ -0.23 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
27.86 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.19.
Pharmacy Services & Retail Drugstore industry's Price to Sales ratio is at 0.23.
• More on NUS's Valuation
|
|
|
|
|
Nu Skin Enterprises Inc realized net loss in trailing twelve months.
Nu Skin Enterprises Inc realized cash outflow of $ -0.23per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
27.86 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.19.
Pharmacy Services & Retail Drugstore industry's Price to Sales ratio is at 0.23.
Nu Skin Enterprises Inc Price to Book Ratio is at 0.5 lower than Industry Avg. of 2779.27. and higher than S&P 500 Avg. of 0.01
• More on NUS's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com